{"title":"Case Report: A promising neoadjuvant treatment option for individuals with locally advanced HER2-positive breast cancer involves the use of Pyrotinib Maleate in combination with Trastuzumab and Pertuzumab","link":"https://www.sciencedirect.com/science/article/pii/S2405844024105427?dgcid=rss_sd_all","date":null,"content":"<p>Publication date: Available online 11 July 2024</p><p><b>Source:</b> Heliyon</p><p>Author(s): Chi Pan, Lan Ge, Huifeng Zhang, Kai Sang, Jian Zhou, Tongbo Yi, Qingtao Ni</p>","author":"","siteTitle":"ScienceDirect Publication: Heliyon","siteHash":"f7bd7e3f1869707615b3e54fb4ebc4eb7c817c729fd5ad33a7fd4ed65328d468","entryHash":"f2a2f1750cf8aa22424af690400cc53c12e212cc8c5be1954c4cbb94620f65ea","category":"Interdisciplinary"}